First Digital Path AI Tool Cleared for Market by FDA

FDA’s action marks start of a new era in pathology where artificial intelligence helps with diagnosis

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email
CEO SUMMARY: In a first for the anatomic pathology profession, the Food and Drug Administration (FDA) has cleared for market a digital pathology image analysis product intended to aid pathologists in the diagnosis of prostate cancer. Developed by New York City-based Paige, the Paige Prostate system was determined by the FDA to improve diagnostic accuracy …

First Digital Path AI Tool Cleared for Market by FDA Read More »

This post is only available to members.

Comments

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.